These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 17661652

  • 21. [Bacteria of the Burkholderia cepacia complex: epidemiology and diagnosis of infection in patients with cystic fibrosis].
    Dřevínek P.
    Epidemiol Mikrobiol Imunol; 2014 Feb; 63(1):18-26. PubMed ID: 24730990
    [Abstract] [Full Text] [Related]

  • 22. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
    De Soyza A, Meachery G, Hester KL, Nicholson A, Parry G, Tocewicz K, Pillay T, Clark S, Lordan JL, Schueler S, Fisher AJ, Dark JH, Gould FK, Corris PA.
    J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
    [Abstract] [Full Text] [Related]

  • 23. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A, Jones AM, Lord R.
    Cochrane Database Syst Rev; 2016 Jan 20; 2016(1):CD009529. PubMed ID: 26789750
    [Abstract] [Full Text] [Related]

  • 24. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P, Whitaker P, Peckham D.
    Curr Med Res Opin; 2012 Jun 20; 28(6):1059-67. PubMed ID: 22401602
    [Abstract] [Full Text] [Related]

  • 25. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A, Scandinavian CF Study Consortium (SCFSC).
    J Cyst Fibros; 2009 Mar 20; 8(2):135-42. PubMed ID: 19157995
    [Abstract] [Full Text] [Related]

  • 26. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
    Baylan O.
    Mikrobiyol Bul; 2012 Apr 20; 46(2):304-18. PubMed ID: 22639321
    [Abstract] [Full Text] [Related]

  • 27. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Jones AM, Dodd ME, Govan JR, Doherty CJ, Smith CM, Isalska BJ, Webb AK.
    Am J Respir Crit Care Med; 2005 Feb 01; 171(3):257-60. PubMed ID: 15542795
    [Abstract] [Full Text] [Related]

  • 28. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Lord R, Jones AM, Horsley A.
    Cochrane Database Syst Rev; 2020 Apr 02; 4(4):CD009529. PubMed ID: 32239690
    [Abstract] [Full Text] [Related]

  • 29. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F, Gözalan A, Ozçelik U, Anadol D, Kiper N, Aktepe OC, Göçmen A, Esen B.
    Mikrobiyol Bul; 2002 Jan 02; 36(1):1-10. PubMed ID: 12476760
    [Abstract] [Full Text] [Related]

  • 30. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G, Petraru E, Dahorea C, Anton DT.
    Rev Med Chir Soc Med Nat Iasi; 2012 Jan 02; 116(2):580-7. PubMed ID: 23077957
    [Abstract] [Full Text] [Related]

  • 31. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP, Brownlee KG, Denton M, Peckham DG.
    Am J Respir Med; 2003 Jan 02; 2(4):321-32. PubMed ID: 14719998
    [Abstract] [Full Text] [Related]

  • 32. A comparison of pulmonary exacerbations with single and multiple organisms in patients with cystic fibrosis and chronic Burkholderia cepacia infection.
    Mc Manus TE, Moore JE, Crowe M, Dunbar K, Elborn JS.
    J Infect; 2003 Jan 02; 46(1):56-9. PubMed ID: 12504610
    [Abstract] [Full Text] [Related]

  • 33. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
    Coutinho CP, Barreto C, Pereira L, Lito L, Melo Cristino J, Sá-Correia I.
    J Med Microbiol; 2015 Aug 02; 64(8):927-935. PubMed ID: 26002942
    [Abstract] [Full Text] [Related]

  • 34. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.
    Reik R, Spilker T, Lipuma JJ.
    J Clin Microbiol; 2005 Jun 02; 43(6):2926-8. PubMed ID: 15956421
    [Abstract] [Full Text] [Related]

  • 35. Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
    Elborn JS, Hodson M, Bertram C.
    J Cyst Fibros; 2009 May 02; 8(3):211-7. PubMed ID: 19372063
    [Abstract] [Full Text] [Related]

  • 36. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?
    Aanaes K, Johansen HK, Skov M, Buchvald FF, Hjuler T, Pressler T, Hoiby N, Nielsen KG, von Buchwald C.
    Rhinology; 2013 Sep 02; 51(3):222-30. PubMed ID: 23943728
    [Abstract] [Full Text] [Related]

  • 37. Temocillin in cystic fibrosis: a retrospective pilot study.
    Kent L, Bradley JM, France M, Döring G, Carryn S, Bradbury I, Rendall J, Jones A, Elborn JS.
    J Cyst Fibros; 2008 Nov 02; 7(6):551-4. PubMed ID: 18706868
    [Abstract] [Full Text] [Related]

  • 38. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.
    Dales L, Ferris W, Vandemheen K, Aaron SD.
    Eur J Clin Microbiol Infect Dis; 2009 Oct 02; 28(10):1275-9. PubMed ID: 19575248
    [Abstract] [Full Text] [Related]

  • 39. [ANTIBIOTICS SENSITIVITY OF STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA AND BACTERIA OF BURKHOLDERIA CEPACIA COMPLEX, PERSISTING IN LUNGS OF PATIENTS WITH MUCOVISCIDOSIS (MV)].
    Avetisyan LR, Chernukha MY, Shaginyan IA, Kapranov NI, Siyanova EA, Medvedeva OS, Kondratieva EI, Alekseeva GV, Krasovsky SA, Usacheva MV, Amelina EL.
    Zh Mikrobiol Epidemiol Immunobiol; 2015 Oct 02; (6):3-10. PubMed ID: 26950982
    [Abstract] [Full Text] [Related]

  • 40. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
    Dobbin C, Maley M, Harkness J, Benn R, Malouf M, Glanville A, Bye P.
    J Hosp Infect; 2004 Apr 02; 56(4):277-82. PubMed ID: 15066737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.